{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:17:50Z","timestamp":1785449870722,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cld.2021.03.004","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T06:20:19Z","timestamp":1621491619000},"page":"585-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessing the Severity and Prognosis of Alcoholic Hepatitis"],"prefix":"10.1016","volume":"25","author":[{"given":"Arnab","family":"Mitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2021.03.004_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cld.2018.09.005","article-title":"Acute alcoholic hepatitis","volume":"23","author":"Im","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2021.03.004_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archinte.168.6.649","article-title":"Epidemiology of alcohol-related liver and pancreatic disease in the United States","volume":"168","author":"Yang","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cld.2021.03.004_bib3","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/ajg.2010.46","article-title":"Alcoholic liver disease-related mortality in the United States: 1980-2003","volume":"105","author":"Paula","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2021.03.004_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","article-title":"The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis","volume":"38","author":"Kulkarni","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2021.03.004_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy for alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.03.004_bib6","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2021.03.004_bib7","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.03.004_bib8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.03.004_bib9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis\u2014a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2021.03.004_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","article-title":"Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables","volume":"37","author":"Christensen","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.cld.2021.03.004_bib11","first-page":"CD001511","article-title":"Glucocorticosteroids for people with alcoholic hepatitis","volume":"11","author":"Pavlov","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2021.03.004_bib12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.03.004_bib13","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2021.03.004_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.03.004_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2021.03.004_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.cld.2021.03.004_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2019.12.023","article-title":"Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis, and Maddrey\u2019s discriminant function < 32","volume":"72","author":"Degre","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.03.004_bib18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis","volume":"42","author":"Srikureja","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2021.03.004_bib19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.hep.2003.09.038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.03.004_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A\u00a0day-4 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","author":"Garcia-Saenz-de-Secilia","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2021.03.004_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-2-2","article-title":"Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis","volume":"2","author":"Sheth","year":"2002","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2021.03.004_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cld.2021.03.004_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.03.004_bib24","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1478-3231.2008.01783.x","article-title":"Interlaboratory availability in assessment of the model of end-stage liver disease score","volume":"28","author":"Lisman","year":"2008","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2021.03.004_bib25","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1136\/gut.2006.099226","article-title":"The Glasgow Alcoholic Hepatitis Score identifies patients who may benefit from corticosteroids","volume":"56","author":"Forrest","year":"2007","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.cld.2021.03.004_bib26","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow Alcoholic Hepatitis Score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cld.2021.03.004_bib27","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A\u00a0new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2021.03.004_bib28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/apt.12654","article-title":"Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort","volume":"39","author":"Papastergiou","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2021.03.004_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2021.03.004_bib30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A\u00a0histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2021.03.004_bib31","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.cgh.2019.11.050","article-title":"Keratin 18 is a diagnostic and prognostic factor for acute alcoholic hepatitis","volume":"18","author":"Vatsalya","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2021.03.004_bib32","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000000912","article-title":"In severe alcoholic hepatitis, serum keratin-18 fragments are diagnostic, prognostic, and theragnostic biomarkers","author":"Atkinson","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2021.03.004_bib33","doi-asserted-by":"crossref","first-page":"498232","DOI":"10.1155\/2012\/498232","article-title":"MicroRNA signature in alcoholic liver disease","volume":"2012","author":"Bala","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.cld.2021.03.004_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-015-0623-9","article-title":"Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis","volume":"13","author":"Momen-Heravi","year":"2015","journal-title":"J\u00a0Transl Med"},{"issue":"2","key":"10.1016\/j.cld.2021.03.004_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jhep.2018.11.025","article-title":"Non-invasive diagnosis and biomarkers in alcohol-related liver disease","volume":"70","author":"Moreno","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.03.004_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11481-009-9185-z","article-title":"Circulating cytokines as biomarkers of alcohol abuse and alcoholism","volume":"5","author":"Achur","year":"2010","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"issue":"3","key":"10.1016\/j.cld.2021.03.004_bib37","doi-asserted-by":"crossref","first-page":"G497","DOI":"10.1152\/ajpgi.00171.2004","article-title":"Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease","volume":"287","author":"McClain","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cld.2021.03.004_bib38","first-page":"835A","article-title":"A novel composite score of biomarkers and age predicts mortality in severe alcoholic hepatitis patients.","volume":"70","author":"Tornai","year":"2019","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2021.03.004_bib39","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1111\/acer.12558","article-title":"Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines","volume":"38","author":"Rachakonda","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.cld.2021.03.004_bib40","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.30617","article-title":"Biomarkers of macrophage activation and immune danger signals predict clinical outcomes in alcoholic hepatitis","volume":"70","author":"Saha","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2021.03.004_bib41","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S0618-8278(19)30083-0","article-title":"Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis.","volume":"70","author":"Forrest","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"15","key":"10.1016\/j.cld.2021.03.004_bib42","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/S0618-8278(19)30192-6","article-title":"Serum bile acid profiles distinguish severe alcoholic hepatitis from decompensated alcohol-related cirrhosis","volume":"70","author":"Tyson","year":"2019","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.cld.2021.03.004_bib43","first-page":"305","article-title":"Malondialdehyde as a prognostic factor in alcoholic hepatitis","volume":"52","author":"Perez-Hernandez","year":"2017","journal-title":"Alcohol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:58:05Z","timestamp":1761069485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326121000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1089326121000283"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2021.03.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the Severity and Prognosis of Alcoholic Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2021.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}